Subscribe free

Newsletter

Intestine and Lower Gastrointestinal Tract

Every new paper in this field, in your inbox.

FreeNo spamOne-click unsubscribe
JAMA Netw Open28 Aug 2024

Accredited hospitals improve treatment and survival for Black patients

Findings indicate that non-Hispanic Black patients with colon cancer treated at Commission on Cancer (CoC)-accredited hospitals received significantly more guideline-concordant care than those treated at non-accredited facilities. Specifically, the odds of undergoing necessary lymphadenectomy and chemotherapy were higher (adjusted odds ratios of 1.89 and 2.31,…

J Gastrointest Surg27 Aug 2024

High social vulnerability increases risks in colon cancer surgery.

Findings revealed that among Medicare patients undergoing colectomy for colon cancer, those in the highest social vulnerability quintile faced a greater likelihood of unplanned surgeries (35.6% vs. 28.9%) and higher 30-day (3.4% vs. 2.9%) and 1-year mortality rates (10.8% vs. 8.6%). The adjusted odds ratios…

Eur J Surg Oncol27 Aug 2024

Circumferential margin involvement shapes outcomes in rectal cancer

A study of 3,020 stage III rectal cancer patients identified that 12.4% had a positive circumferential resection margin (CRM). Notably, CRM involvement predominantly occurred through primary tumor invasion (63.2%). Local recurrence and distant metastasis rates varied, being lowest with lymph node metastasis and highest with…

Int J Colorectal Dis26 Aug 2024

Nomogram predicts postoperative complications in rectal cancer surgery

A nomogram was developed to predict postoperative complications in 207 patients with middle and low rectal cancer undergoing transanal total mesorectal excision (TATME). Findings indicated that 27.5% of patients experienced complications. Key predictors included operation time, smoking history, anastomotic technique, and ASA score, each significantly…

Intestine and Lower Gastrointestinal Tract26 Aug 2024

Indocyanine green fluorescence reduces anastomotic leak rates.

A systematic review and meta-analysis of six randomized trials, including 1949 patients, demonstrated that indocyanine green (ICG) fluorescence significantly reduces anastomotic leak rates in left-sided colorectal resections. The pooled odds ratio showed a 4.7% absolute reduction in leak rates (OR: 0.586, 95% CI: 0.434-0.792), indicating…

J Gastrointest Surg25 Aug 2024

Preoperative carbohydrate loading improves surgical outcomes in colorectal surgery.

Oral carbohydrate loading before elective colorectal surgery significantly reduces postoperative insulin resistance, inflammatory markers, and improves patient well-being. In a randomized controlled trial with 72 participants, the carbohydrate loading group showed a marked decrease in insulin resistance on the day of surgery and postoperatively. Additionally,…

J Gastrointest Surg25 Aug 2024

Increased complete response rates observed in total neoadjuvant therapy

Among 339 patients with locally advanced rectal cancer, 208 (61.3%) completed total neoadjuvant therapy, achieving a final complete response (CR) rate of 42.3%. Notably, 57 patients (27.4%) sustained clinical CR for over a year, while 42 patients showed pathologic CR post-surgery. Predictors of CR included…

Int J Surg24 Aug 2024

Rectal preservation is viable in most rectal cancer cases

In a multicenter study of 178 patients with mid-low rectal adenocarcinoma, 80.9% maintained rectal preservation after neoadjuvant treatment using either transanal local excision or a watch-and-wait approach. Overall survival at three years was 80.6%, while disease-free survival reached 97.6%. Local recurrence-free and distant recurrence-free survival…

Surg Endosc23 Aug 2024

Robot-assisted pelvic exenteration offers significant surgical benefits

A multicenter analysis revealed that robot-assisted pelvic exenteration (RPE) significantly reduces blood loss, transfusion rates, and postoperative complications compared to open (OPE) and laparoscopic pelvic exenteration (LPE). Specifically, RPE resulted in blood loss of 408 ml versus 2385 ml for OPE, with a transfusion rate…

Tech Coloproctol21 Aug 2024

RD2 Ver.02 shows promising efficacy in treating pilonidal sinus

In a phase II study involving 51 patients with pilonidal sinus (PNS), RD2 Ver.02 demonstrated significant results. Three months post-treatment, 82.4% achieved primary healing, increasing to 90.2% and 82.4% at six and twelve months, respectively. Recurrence occurred in 11.8% of patients within a year, while…